Skip to main content
OpenTrials
Completed

NCT Number: NCT00243126

Family-based HIV Prevention for Adolescent Girls

This is an exploratory/developmental study to support the early phases of development and evaluation of a family-based HIV prevention program for adolescent girls prior to a full-scale trial. Research on the new intervention will include evaluating the feasibility, tolerability, and acceptability of the intervention, and allow us to obtain the preliminary data needed as a pre-requisite to a larger-scale intervention study.

Adolescent females and their mother/guardian will be randomized to either: a family-based risk reduction intervention; or a no-treatment control group condition. Participants in both conditions will be assessed at baseline, immediate post-intervention, and at 3- and 6-month follow-ups. A subset of families (12 adolescents and 12 mothers) will participate in a qualitative interview following the 6-month follow-up, in which information will be obtained on participant perception of procedures and intervention content, and whether they have utilized skills taught following the end of the project.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–19 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

John H. Stroger Jr. Hospital and the Core Center, Chicago, Illinois, United States

Loading trial locations.

About this study

Participants will be involved with the study and follow up for a total of 32 to 36 weeks.

68-84 female adolescents and their mother/guardian (total N = 136-168).

African American or mixed race, sexually active female adolescents age 15 to 19 who are at risk for HIV infection and their mother/guardian

The adolescent participant and her mother/guardian will be randomized to either a family-based risk reduction intervention or a no-treatment control group condition.

Participants in both conditions will be assessed at baseline, immediate post-intervention, and at 3- and 6-month follow-ups. A subset of 24 participants from the intervention condition (12 adolescents and 12 mothers) will participate in a qualitative interview following the 6-month follow-up, in which information will be obtained on participant perception of procedures and intervention content, and whether they have utilized skills taught following the end of the project.

Interviewers will collect participant data from the baseline and follow-up behavioral interviews using a Computer Assisted Personal Interviewing (CAPI) method on a portable computer.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Between the age of 15 years and 0 days and 19 years and 364 days at the time of initial eligibility screening.
  • Born in the United States
  • Self identifies as all or part African American.
  • Sexually active, defined as having had vaginal or anal intercourse
  • Has engaged in unprotected sex during the past 3 months
  • Is willing to invite and participate with her mother/guardian in the intervention
  • Has either a biological mother or a guardian who is willing to participate in the study and meets the eligibility criteria

For the purposes of this pilot study, biological mothers are eligible, as are non-biological primary caretakers serving as mother/guardians who have guardianship of the adolescent and with whom the adolescent is living.

  • Able to understand spoken and written English sufficiently to provide assent/consent and to be interviewed and participate in the study intervention.
  • Not intending to relocate out of the current geographical area for the duration of study participation.
  • Provides informed assent or consent

Mother or Mother/guardian

  • Has legal guardianship; and
  • Currently resides with the adolescent.
  • Self identifies as all or part African American.
  • Born in the United States
  • Able to understand spoken and written English sufficiently to provide consent and to be interviewed and participate in the study intervention.
  • Not intending to relocate out of the current geographical area for the duration of study participation.
  • Provides informed consent

Exclusion criteria

  • Adolescent is currently pregnant or has carried a pregnancy to term
  • Adolescent self-reports as HIV positive

Treatment and study plan

Family-Based Risk Reduction Intervention

Behavioral

The intervention module topics include five modules and each module is 2 hours in length. The intervention will focus on the elements critical to HIV risk behavior change. These include: risk education (practical understanding of factors responsible for risk and behavior changes needed to reduce risk); threat personalization (accurate appraisal of personal risk based on behavior); self-efficacy (belief that one can implement risk reduction behavior changes and that if changes are made they will have protective value); skills acquisition (e.g., condom use, safer sex guidance, negotiation); cognitive problem-solving skills; and reinforcement.

Primary outcomes

  1. Test the feasibility of implementing intervention

    Time frame: 32-26 Weeks

    The primary objective of this pilot study is to test the feasibility of implementing a mother-daughter HIV risk reduction intervention for at-risk female adolescents.

Secondary outcomes

  1. Conduct a preliminary efficacy test of the intervention

    Time frame: 32-36 Weeks

    The secondary objective of this pilot study is to conduct a preliminary efficacy test of the intervention to determine if trends towards significant effects for reducing unprotected sex and/or reducing substance use are found.

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • National Institute of Mental Health (NIMH)
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

Family-based HIV Prevention for Adolescent Females

Important dates

Study start
2005
Primary completion
2006
Study completion
2006
First posted
Oct 21, 2005
Registry last updated
Mar 1, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.